CTT Pharmaceutical Holdings (CTTH) Stock Price & Analysis

CTTH Stock Chart & Stats

$0.06$0.00(7.27%)

At close: Oct 30 4:00 PM EDT

Day’s Range: $0.06 - $0.06
52-Week Range: $0.04 - $0.10
Previous Close: $0.06
Volume: 100
Average Volume (3M): 13.16K
Market Cap: $3.52M
Enterprise Value: $1.71T
Total Cash (Recent Filing): $31
Total Debt (Recent Filing): $19.44K
Price to Earnings (P/E): ―
Beta: 0.16
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

CTT Pharmaceutical Holdings News

CTT Pharmaceutical appoints new PCAOB auditor, ensuring continuity

CTT Pharmaceutical Holdings ( ($CTTH) ) just unveiled an update. CTT Pharmaceutical Holdings, Inc., an OTCQB-listed drug development company, reported that its former certifying public accountant, Holt & Patterson, resigned

2d ago8K CTTH

CTT Pharmaceutical Adds Karen Larson to Board

An update from CTT Pharmaceutical Holdings ( ($CTTH) ) is now available. CTT Pharmaceutical Holdings, Inc. has appointed Karen Larson as an independent member of its board, adding deep financial

1M ago8K CTTH

CTT Pharmaceutical expands patent protection for delivery technology

The latest update is out from CTT Pharmaceutical Holdings ( ($CTTH) ). On August 10, 2026, CTT Pharmaceutical Holdings announced that the U.S. Patent Office had approved a continuation-in-part patent

2M ago8K CTTH

CTTH FAQ

What was CTT Pharmaceutical Holdings’s price range in the past 12 months?

CTT Pharmaceutical Holdings lowest stock price was $0.04 and its highest was $0.10 in the past 12 months.

What is CTT Pharmaceutical Holdings’s market cap?

CTT Pharmaceutical Holdings’s market cap is $3.52M.

When is CTT Pharmaceutical Holdings’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is CTT Pharmaceutical Holdings overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does CTT Pharmaceutical Holdings pay dividends?

CTT Pharmaceutical Holdings does not currently pay dividends.

What is CTT Pharmaceutical Holdings’s EPS estimate?

CTT Pharmaceutical Holdings’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does CTT Pharmaceutical Holdings have?

CTT Pharmaceutical Holdings has 59,722,233 shares outstanding.

Which hedge fund is a major shareholder of CTT Pharmaceutical Holdings?

Currently, no hedge funds are holding shares in CTTH

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description